InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（3 笔）
内部人交易记录
其他已披露买入
0
已披露卖出
3
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the detailed record of transactions filed by Summit Partners Growth Equity Fund IX-A, L.P.. Director active across 2 companies, notably LifeStance Health Group, Inc.. Cumulatively, 3 filings have been logged. Split: 0 buy · 3 sells. Total volume traded: €56.2m. Activity tracked since 14 June 2021. The latest transaction was filed on 24 May 2024 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Summit Partners Growth Equity Fund IX-A, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报3 总计
3,802,345 股@ US$5.89100.0% 占其流量Common StockSEC:0000950170-24-066078:0
1,140,704 股@ US$17.0145.9% 占其流量Common StockSEC:0001179110-21-007118:0
1,368,844 股@ US$17.0154.1% 占其流量Common StockSEC:0001179110-21-006787:0
3 条申报中的 3 条
About Summit Partners Growth Equity Fund IX-A, L.P.
Summit Partners Growth Equity Fund IX-A, L.P. is a declarant linked to LifeStance Health Group, Inc. on XNAS. The declarant has filed 5 filings in total, and in the recent filings we hold, the transactions are sales, with EUR 0 of buys and EUR 91655760 of sells between 2021-06-16 and 2024-05-29.
